跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Risperi - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Risperi
Approved
STANDARD
Risperi
LIFESQUARE LABORATORIES INC.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ecb588e9e6077744
Company
LIFESQUARE LABORATORIES INC.
Type
Standard
Approval Details
Approval Id
ecb588e9e6077744
Drug Approval Philippines Name
Risperi
Product Name
Risperi
Registration Number
DRP-6729-04
Brand Name
Risperi
Generic Name
Risperidone
Dosage Form
Tablet
Dosage Strength
2 mg
Manufacturer
LIFESQUARE LABORATORIES INC.
Distributor
ALTERNATIVE PLATFORM EXCHANGE INC.
Issuance Date
24 May 2024
Expiry Date
20 June 2029
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ecb588e9e6077744
Type
Standard
Back to Philippines FDA Approvals